Prediction: New Reason Lilly Stock Could Still Rise
Eli Lilly stock could advance in the second half of 2026 as Foundayo gains traction and the GLP-1 franchise shines, b...
Discover the key moments for choosing short term investments. Timing your investments can significantly impact your returns.
26,180 articlesEli Lilly stock could advance in the second half of 2026 as Foundayo gains traction and the GLP-1 franchise shines, b...
A joint U.S.-Russian crew has arrived at the ISS, signaling continued cooperation in orbit even as global tensions pe...
Hyperion, a public hyperliquid treasury firm, announces a 500,000 HYPE token deal with Skew under a HAUS agreement, e...
July 2026 brings oil swings and EV demand shifts, narrowing the window for bold bets. A trio—Tesla, Rivian, and NIO—c...
AI chips are reshaping tech, and ARM Holdings could ride the wave as a major royalty player. This article explains wh...
Mizuho analysts warn that the clarity act’s impact circle could weigh on Circle in the long run, citing higher compli...
Elon Musk is pursuing a bold plan to run AI data centers in space, backed by SpaceX filings and xAI ambitions. But in...
Ultra-prime Manhattan sales are accelerating even as policy debates intensify. Brokers say buyers and sellers remain ...
President Donald Trump announces a sweeping 10% global tariff on imports, seeking to salvage a faltering trade agenda...
A new moisture-absorbing paint-and-primer system backed by large homebuilders is entering the market, promising to re...
AMH reports solid 2025 results as it navigates an overbuilt rental market, with revenue gains driven by disciplined a...
Salesforce heads into a pivotal Q4 showing whether Agentforce can convert hype into durable revenue. A strong read co...